CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine
The personalised vaccine has succeeded in a final-stage melanoma trial. Here’s how it works, when it could become available and why researchers hope the approach can be used against other cancers.
We haven't written up this one. Channel News Asia has the full story — the link below goes straight to it.